HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Randomized Clinical Trial of Immediate versus Delayed Glasses for Moderate Hyperopia in 1- and 2-Year-Olds.

AbstractPURPOSE:
Two strategies were compared for managing moderate hyperopia without manifest strabismus among 1- and 2-year-old children: (1) immediate prescription of glasses versus (2) observation without glasses unless reduced distance visual acuity (VA), reduced stereoacuity, or manifest strabismus.
DESIGN:
Prospective randomized clinical trial.
PARTICIPANTS:
A total of 130 children aged 1 to 2 years with hyperopia between +3.00 diopters (D) and +6.00 D spherical equivalent (SE) in at least 1 eye, anisometropia ≤1.50 D SE, and astigmatism ≤1.50 D based on cycloplegic refraction and no manifest strabismus.
METHODS:
Participants were randomly assigned to glasses (1.00 D less than full cycloplegic hyperopia) versus observation and followed every 6 months for 3 years. Glasses were prescribed to those assigned to observation if they met prespecified deterioration criteria of distance VA or near stereoacuity below age norms, or development of manifest strabismus.
MAIN OUTCOME MEASURES:
At the 3-year primary outcome examination, participants were classified as failing the randomized management regimen if distance VA or stereoacuity was below age norms or manifest strabismus was observed (each with and without correction in trial frames, confirmed by masked retest, irrespective of whether deterioration had occurred previously), or if strabismus surgery had been performed.
RESULTS:
Of the 106 participants (82%) completing the 3-year primary outcome examination, failure occurred in 11 (21%) of 53 in the glasses group and 18 (34%) of 53 in the observation group (difference = -13%; 95% confidence interval [CI], -31 to 4; P = 0.14). Sixty-two percent (95% CI, 49-74) in the observation group and 34% (95% CI, 23-48) in the glasses group met deterioration criteria (requiring glasses if not wearing).
CONCLUSIONS:
For 1- and 2-year-olds with uncorrected moderate hyperopia (+3.00 D to +6.00 D SE), our estimates of failure, after 3 years of 6-month follow-ups, are inconclusive and consistent with a small to moderate benefit or no benefit of immediate prescription of glasses compared with careful observation (with glasses only if deteriorated).
AuthorsPediatric Eye Disease Investigator Group, Marjean T Kulp, Jonathan M Holmes, Trevano W Dean, Donny W Suh, Raymond T Kraker, David K Wallace, David B Petersen, Susan A Cotter, Ruth E Manny, Rosanne Superstein, Tawna L Roberts, John M Avallone, Deborah R Fishman, S Ayse Erzurum, David A Leske, Alex Christoff
JournalOphthalmology (Ophthalmology) Vol. 126 Issue 6 Pg. 876-887 (06 2019) ISSN: 1549-4713 [Electronic] United States
PMID30615896 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Topics
  • Anisometropia (physiopathology)
  • Astigmatism (physiopathology)
  • Child, Preschool
  • Depth Perception (physiology)
  • Eyeglasses
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperopia (physiopathology, therapy)
  • Infant
  • Male
  • Patient Compliance
  • Prescriptions
  • Prospective Studies
  • Time-to-Treatment
  • Vision Tests
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: